Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19,449 | 19,445 | 11,647 | 2,706 | 2,761 |
| Income taxes - deferred | -176,194 | N/A | N/A | N/A | N/A |
| Accounts receivable | -4,910 | -12,455 | -10,606 | 1,927 | -15,415 |
| Accounts payable and accrued liabilities | -1,874 | 860 | 13,394 | N/A | N/A |
| Other Working Capital | -8,783 | 5,448 | -5,608 | -6,817 | -21,633 |
| Other Operating Activity | 307,970 | 31,090 | -42,288 | -77,345 | -123,405 |
| Operating Cash Flow | $135,658 | $44,388 | $-33,461 | $-79,529 | $-157,692 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -252 | -281 | -718 | -292 | -297 |
| Purchase Of Investment | -526,650 | -545,832 | -523,500 | -523,993 | -438,958 |
| Sale Of Investment | 494,134 | 585,418 | 529,376 | 464,316 | 354,427 |
| Purchase Sale Intangibles | N/A | N/A | 0 | 0 | -1,198 |
| Other Investing Activity | 0 | -43 | -11,864 | -663 | -17,844 |
| Investing Cash Flow | $-32,768 | $39,262 | $-6,706 | $-60,632 | $-103,870 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13,136 | -11,989 | -10,025 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 0 | 0 | 196,740 |
| Common Stock Repurchased | -98,156 | -40,239 | N/A | N/A | N/A |
| Other Financing Activity | 5,182 | 3,136 | 4,895 | 2,433 | 24,372 |
| Financing Cash Flow | $-106,110 | $-49,092 | $-5,130 | $2,433 | $221,112 |
| Beginning Cash Position | 83,433 | 48,875 | 94,172 | 231,900 | 272,350 |
| End Cash Position | 80,213 | 83,433 | 48,875 | 94,172 | 231,900 |
| Net Cash Flow | $-3,220 | $34,558 | $-45,297 | $-137,728 | $-40,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | 135,658 | 44,388 | -33,461 | -79,529 | -157,692 |
| Capital Expenditure | -252 | -281 | -718 | -292 | -1,501 |
| Free Cash Flow | 135,406 | 44,107 | -34,179 | -79,821 | -159,193 |